Interbrand
-
Franchise India Bureau Jan 16 2018 - 2 min readDrug major Lupin said it has forayed into over-the-counter (OTC) segment in the country with plans to touch Rs 300 crore turnovers in the vertical over the next five years. The Mumbai-based firm has introduced its legacy product 'Softovac' across the country as an OTC medicine. Lupin Head OTC Business Anil Kaushal said “It was ...